Europe Diagnostics Market By Product (Instruments, Reagents, Software & Services), By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others), By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others), By Country, Competition, Forecast & Opportunities, 2028

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Europe diagnostics market is expected to grow at an impressive rate during the forecast period, 2024-2028. Growing incidences of various diseases along with extensive technological advancements in the country is likely to propel the growth of the market. Clinical diagnostics has open up new possibilities for early prevention and intervention by identifying the risk factors and early warning indications in a patient. As a result, it is projected that the entire market would continue to grow as the occurrences of chronic illnesses rises. Also, there is an increase in In-vitro diagnostic tests as well as increasing demand for genetic testing, which, in turn is surging the growth of the market.

Additionally, growing demand for Point-of-Care testing is a major factor for the market’s growth. This can be attributed to surging demand for self-testing diagnostics, and also the patient awareness regarding early diagnosis of the diseases. The growing popularity of personalized medicine among people for the treatments of several chronic diseases is likely to create lucrative opportunities for market growth over the next few years.

Growing Prevalence of Several Diseases and Disorders

Growing incidences and prevalence of lifestyle disorders such as hypertension, cardiovascular diseases, cancer, diabetes, among others, is expected to bolster the growth of the market. According to the Global Cancer Observatory report, in 2020, 4,398,443 European people were suffering from cancer, out of which 1,955,231 people lost their lives due to cancer. Additionally, people are becoming more aware about the early diagnosis and treatment of the chronic diseases, which, in turn, surges the demand for diagnostic tests. Therefore, these factors are anticipated to facilitate the growth of the market.

Increasing Aging Population

The rising geriatric population is increasing the risk of getting several diseases including heart strokes, cancer, cardiovascular diseases, neurological disorders, and diabetes in the country is facilitating the growth of the market. For instance, in 2021, Europe has largest proportion of the ageing population with 19%, where Germany is the country that contributed the most to the older population with 17.78 million, followed by Italy with 13.76 million, France with 13.16 million, and the United Kingdom with 12.24 million.

Recent Developments: 

  • In 2021, Roche introduced its Cobas Pulse System in select countries accepting CE mark approval in Europe. The item is a networked point-of-care solution from Roche Diagnostics' latest generation. The most recent release offers expert blood glucose management.
  • In 2021, Hologic announced the European launch of Genius™ Digital Diagnostics System for cervical cancer screening. It is the next generation of cervical cancer screening that merge deep learning-based artificial intelligence (AI) with advanced volumetric imaging technology to assist in identifying pre-cancerous lesions and cervical cancer cells in women. It was developed to offer actionable insights, and to improve workflow and lab efficiency, which primarily focus on eradicating cervical cancer.


Download Free Sample Report

Market Segmentation

Europe diagnostics market is segmented into product, technology, application, end user, company and region. Based on product, the market is categorized into instruments, reagents, and software & services. Based on technology, the market is divided into immunoassay, hematology, clinical chemistry, molecular diagnostics, microbiology, and others. Based on application, the market can be divided into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. Based on end user, the market is bifurcated into hospitals & clinics, diagnostic centers & laboratories, and others. In term of countries, the market is segmented into France, Germany, United Kingdom, Italy, Spain, Finland, Greece, Portugal, Bulgaria, and Croatia. 

Market Players

Roche Diagnostics GmbH, Ortho Clinical Diagnostics., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., and Siemens Healthcare GmbH are some of the leading companies operating in the Europe Diagnostics Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Technology

·         Application

·         End User

·         Country

Country scope

France, Germany, United Kingdom, Italy, Spain, Finland, Greece, Portugal, Bulgaria, and Croatia.

Key companies profiled

Roche Diagnostics GmbH, Ortho Clinical Diagnostics., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., Siemens Healthcare GmbH.

Customization scope

10% free report customization with purchase. Addition or alteration to country, & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, Europe diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Europe Diagnostics Market, By Product:
    • Instruments
    • Reagents
    • Software & Services
  • Europe Diagnostics Market, By Technology:
    • Immunoassay
    • Hematology
    • Clinical Chemistry
    • Molecular Diagnostics
    • Microbiology
    • Others
  • Europe Diagnostics Market, By Application:
    • Infectious Diseases
    • Diabetes
    • Oncology
    • Cardiology
    • Nephrology
    • Others
  • Europe Diagnostics Market, By End User:
    • Hospitals & Clinics
    • Diagnostic Centers & Laboratories
    • Others
  • Europe Diagnostics Market, By Country:
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
    • Finland
    • Greece
    • Portugal
    • Bulgaria
    • Croatia.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Europe diagnostics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Europe Diagnostics Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Instruments, Reagents, Software & Services)

5.2.2.     By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others)

5.2.3.     By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others)

5.2.4.     By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others)

5.2.5.     By Country

5.2.6.     By Company (2022)

5.3.  Market Map

5.3.1.     By Product

5.3.2.     By Technology

5.3.3.     By Application

5.3.4.     By End User

5.3.5.     By Country

5.4.  Europe: Country Analysis

5.4.1.     France Diagnostics Market Outlook

5.4.1.1.         Market Size & Forecast

5.4.1.1.1.             By Value

5.4.1.2.         Market Share & Forecast

5.4.1.2.1.             By Product

5.4.1.2.2.             By Technology

5.4.1.2.3.             By Application

5.4.1.2.4.             By End User

5.4.2.     Germany Diagnostics Market Outlook

5.4.2.1.         Market Size & Forecast

5.4.2.1.1.             By Value

5.4.2.2.         Market Share & Forecast

5.4.2.2.1.             By Product

5.4.2.2.2.             By Technology

5.4.2.2.3.             By Application

5.4.2.2.4.             By End User

5.4.3.     United Kingdom Diagnostics Market Outlook

5.4.3.1.         Market Size & Forecast

5.4.3.1.1.             By Value

5.4.3.2.         Market Share & Forecast

5.4.3.2.1.             By Product

5.4.3.2.2.             By Technology

5.4.3.2.3.             By Application

5.4.3.2.4.             By End User

5.4.4.     Italy Diagnostics Market Outlook

5.4.4.1.         Market Size & Forecast

5.4.4.1.1.             By Value

5.4.4.2.         Market Share & Forecast

5.4.4.2.1.             By Product

5.4.4.2.2.             By Technology

5.4.4.2.3.             By Application

5.4.4.2.4.             By End User

5.4.5.     Spain Diagnostics Market Outlook

5.4.5.1.         Market Size & Forecast

5.4.5.1.1.             By Value

5.4.5.2.         Market Share & Forecast

5.4.5.2.1.             By Product

5.4.5.2.2.             By Technology

5.4.5.2.3.             By Application

5.4.5.2.4.             By End User

5.4.6.     Finland Diagnostics Market Outlook

5.4.6.1.         Market Size & Forecast

5.4.6.1.1.             By Value

5.4.6.2.         Market Share & Forecast

5.4.6.2.1.             By Product

5.4.6.2.2.             By Technology

5.4.6.2.3.             By Application

5.4.6.2.4.             By End User

5.4.7.     Greece Diagnostics Market Outlook

5.4.7.1.         Market Size & Forecast

5.4.7.1.1.             By Value

5.4.7.2.         Market Share & Forecast

5.4.7.2.1.             By Product

5.4.7.2.2.             By Technology

5.4.7.2.3.             By Application

5.4.7.2.4.             By End User

5.4.8.     Portugal Diagnostics Market Outlook

5.4.8.1.         Market Size & Forecast

5.4.8.1.1.             By Value

5.4.8.2.         Market Share & Forecast

5.4.8.2.1.             By Product

5.4.8.2.2.             By Technology

5.4.8.2.3.             By Application

5.4.8.2.4.             By End User

5.4.9.     Bulgaria Diagnostics Market Outlook

5.4.9.1.         Market Size & Forecast

5.4.9.1.1.             By Value

5.4.9.2.         Market Share & Forecast

5.4.9.2.1.             By Product

5.4.9.2.2.             By Technology

5.4.9.2.3.             By Application

5.4.9.2.4.             By End User

5.4.10.  Croatia Diagnostics Market Outlook

5.4.10.1.      Market Size & Forecast

5.4.10.1.1.           By Value

5.4.10.2.      Market Share & Forecast

5.4.10.2.1.           By Product

5.4.10.2.2.           By Technology

5.4.10.2.3.           By Application

5.4.10.2.4.           By End User

6.    Market Dynamics

6.1.  Drivers

6.2.  Challenges

7.    Market Trends & Developments

8.    Competitive Landscape

8.1.  Business Overview

8.2.  Product Offerings

8.3.  Recent Developments

8.4.  Financials (As Reported)

8.5.  Key Personnel

8.6.  SWOT Analysis

8.6.1.     Roche Diagnostics GmbH

8.6.2.     Ortho Clinical Diagnostics

8.6.3.     Abbott Laboratories, Inc.

8.6.4.     Hologic, Inc. (Gen-Probe)

8.6.5.     Qiagen N.V.

8.6.6.     Bio-Rad Laboratories, Inc.

8.6.7.     Quidel Corporation

8.6.8.     Becton, Dickinson (BD) Company, Inc.

8.6.9.     bioMerieux, Inc.

8.6.10.  Siemens Healthcare GmbH

9. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Rising incidences of chronic diseases, and extensive use of advanced technology are driving the demand for the Europe diagnostics market.

down-arrow

Roche Diagnostics GmbH, Ortho Clinical Diagnostics., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., and Siemens Healthcare GmbH. are the key players operating in the Europe diagnostics market.

down-arrow

By application, the market is segmented into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. Oncology is anticipated to hold the largest revenue shares of the Europe diagnostic market in the upcoming five years. This is due to increasing demand for early diagnosis of oncological cells and cancerous tumor in the patient for timely and effective treatment.

down-arrow

The affordability for high-end molecular diagnostics along with the limitations associated with reimbursement scenario are likely to hamper the growth of Europe diagnostics market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Europe Diagnostics Market to Witness Significant Growth until 2025

May, 2020

Increasing geriatric population is expected to drive the growth of Europe diagnostics market

Why Choose Us